Axithra’s solution for actionable therapeutic drug monitoring (TDM) in patients allows a shift in the treatment paradigm towards personalized medicine. Their initial focus is antibiotics which play a life-saving role in the treatment of critically-ill patients in intensive care units (ICUs), reducing both patient morbidity and mortality.